Cardiac device makers Edwards, JenaValve elicit US FTC merger challenge

Cardiology technology developer Edwards Lifesciences Corporation’s proposed $945 million acquisition of rival JenaValve Technology was challenged in a lawsuit filed today by the US Federal Trade Commission, whose three Republican commissioners...

Already a subscriber? Click here to view full article